My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Archivos de la Sociedad Española de Oftalmología
Print version ISSN 0365-6691
Abstract
GONZALEZ-GOMEZ, A.; MORILLO, M.J.; GONZALEZ-ESCOBAR, A.B. and GARCIA-CAMPOS, J.M.. Choroidal neovascularization secondary to pseudoxanthoma elasticum treated with ranibizumab: a report of 2 cases. Arch Soc Esp Oftalmol [online]. 2012, vol.87, n.5, pp.153-156. ISSN 0365-6691.
Case report: We report 2 cases of pseudoxanthoma elasticum with angioid streaks and choroidal neovascularization (CNV) in both eyes. Intravitreal ranibizumab (Lucentis) was administered with successful results in both cases. Discussion: CNV has been reported to occur in 72% to 86% of patients with angioid streaks. Although uncommon, the impact of CNV is important because it tends to affect people of working age. Based on the effectiveness of ranibizumab in other secondary CNVs, we decided to use it in our patients, observing the functional and anatomical improvement.
Keywords : Angioid streaks; Ranibizumab; Choroidal neovascularization; Pseudoxanthoma elasticum.